• Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
  • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
WNX [Page4 - Thumbnail]

Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024

Wellnex Life (ASX:WNX): Investor Briefing with Managing Director Zack Bozinovski and Non-Executive Chairman George Tambassis...

2024-10-12-WNX-NM

Wellnex ready for dual UK listing in new year after record November sales

Special Report: As Wellnex Life targets a dual listing on the London Stock Exchange (LSE) early...

Woman meditating on the beach at sunset.

ASX wellness stocks offering calm and anxiety relief – Part 2

Australians are increasingly feeling overwhelmed by the daily juggle of life’s responsibilities with financial strain...

WNX [Page 2 - Thumbnail]

Wellnex Life (ASX:WNX) Q&A – 9th February 2024

Wellnex Life (ASX:WNX): Q&A with Managing Director Zack Bozinovski and Non-Executive Chairman Mario Tascone In...

WNX [Page 1 - Thumbnail]

Wellnex Life (ASX:WNX) Investor Briefing & Q&A – 14th December 2023

Wellnex Life (ASX:WNX): Investor Briefing & Q&A with Managing Director Zack Bozinovski, CEO George Karafotias...

WNX-Vested-640x360

Wellnex Life to rise 117pc in next 12 months forecasts Vested Equities

Special Report: Vested Equities has initiated coverage on Wellnex Life with an overweight rating and 11.5...

Happy family: mother, father, children son and  daughter on nature  on sunset

Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health

Emyria has announced a number of changes to its board as the ASX-listed firm looks...

wnxnews

Wellnex Life sees growth accelerating following acquisition of Pain Away brand

In a recent interview with Proactive, Wellnex Life Ltd (ASX:WNX) CEO George Karafotias outlined the company's recent...

36412-wnx-1280x720-800x430

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year...

Barclay Pearce

Wellnex Life’s Investor Highlights – Corporate Showcase Interview

Hear Zack Bozinovski, Managing Director of Wellnex Life outline the company story, investor highlights and the strategy...

Posts pagination

Previous1 2 … 15 Next
RECENT POSTS
  • Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
  • Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
  • Wellnex ready for dual UK listing in new year after record November sales
  • ASX wellness stocks offering calm and anxiety relief – Part 2
  • Wellnex Life (ASX:WNX) Q&A – 9th February 2024
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2022 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)